Dapsone Gel
Product Images NDC 51862-123

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dapsone (NDC 51862-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dapsone 01)

Chemical structure of dapsone, showing two benzene rings linked by a sulfone (SO2) group with amino (NH2) substituents on each benzene ring.*

FDA Label Image

Principal Display Panel (60 g Tube Carton)

Packaging label for Dapsone Gel 5% topical gel, 60 g. The label states the active ingredient strength as 50 mg of dapsone per gram of gel. It includes warnings for topical use only and dosage instructions to apply twice daily. The labeler is Mayne Pharma, with manufacturing by Encube Ethicals Pvt. Ltd. in India and distribution by Mayne Pharma in Greenville, NC. The package includes regulatory and storage information, barcode, and revision date 11/2023.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.